Robert Chess
Director at Nektar Therapeutics (NKTR)
Robert Chess has filed 40 insider reports with the SEC since February 2021, as director at Nektar Therapeutics (NKTR) and director at Twist Bioscience Corp (TWST). In the last 12 months Robert Chess sold $2.62M of stock on the open market. The latest filing, on September 26, 2026, reports grant or award at Nektar Therapeutics (NKTR).
- Filings
- 40
- Companies
- 2
- Bought on market
- None
- Sold on market
- $6.9M
Companies where Robert Chess is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 19,019 | $824K | $35.91 | Sep 26, 2026 | |||
| Director | 21,084 | $6.07M | $112.00 | Aug 11, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 23, 2026NKTRDirector Chess Robert was granted 2,000 shares, increasing direct ownership by 12% to 19,019 unitsForm 4Grant or award
- Aug 7, 2026-$2.04MTWSTDirector Chess Robert sold $2,042,261 worth of shares (18,417 units at $110.89) as part of a pre-agreed trading plan and exercised 18,417 shares at a strike of $11.89Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 7, 2026~$2.04MTWSTRobert Chess plans to sell 18,417 shares (~$2.04M)Form 144Planned sale10b5-1 plan
- Mar 17, 2026-$470KTWSTSEC Form 4 filed by Chess RobertForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 17, 2026~$470KTWSTRobert Chess plans to sell 10,000 shares (~$470K)Form 144Planned sale10b5-1 plan
- Feb 13, 2026-$105KTWSTDirector Chess Robert sold $105,402 worth of shares (2,184 units at $48.26), decreasing direct ownership by 9% to 21,084 unitsForm 4Open-market sale
- Feb 13, 2026~$105KTWSTRobert Chess plans to sell 2,184 shares (~$105K)Form 144Planned sale
- Feb 5, 2026TWSTDirector Chess Robert was granted 5,095 shares, increasing direct ownership by 28% to 23,268 unitsForm 4Grant or award
- Sep 30, 2025NKTRSEC Form 4 filed by Director Chess RobertForm 4Grant or award
- Feb 7, 2025-$156KTWSTDirector Chess Robert sold $156,217 worth of shares (2,940 units at $53.13), decreasing direct ownership by 14% to 18,173 unitsForm 4Open-market sale
- Feb 5, 2025TWSTDirector Chess Robert was granted 4,472 shares, increasing direct ownership by 27% to 21,113 unitsForm 4Grant or award
- Jan 18, 2025NKTRSEC Form 5 filed by Chess RobertForm 5
- Jan 7, 2025-$250KTWSTDirector Chess Robert sold $250,000 worth of shares (5,000 units at $50.00), decreasing direct ownership by 23% to 16,641 unitsForm 4Open-market sale10b5-1 plan
- Dec 5, 2024-$182KTWSTDirector Chess Robert exercised 3,504 shares at a strike of $8.82 and sold $181,696 worth of shares (3,504 units at $51.85)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 5, 2024~$182KTWSTRobert Chess plans to sell 3,504 shares (~$182K)Form 144Planned sale10b5-1 plan
- Nov 11, 2024-$170KTWSTDirector Chess Robert exercised 3,600 shares at a strike of $8.82 and sold $170,139 worth of shares (3,600 units at $47.26)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 14, 2024-$23.4KNKTRDirector Chess Robert sold $23,400 worth of shares (19,500 units at $1.20), decreasing direct ownership by 7% to 255,273 unitsForm 4Open-market sale10b5-1 plan
- Feb 8, 2024-$144KTWSTChess Robert was granted 5,815 shares and sold $143,784 worth of shares (4,110 units at $34.98), increasing direct ownership by 3% to 64,169 unitsForm 4Grant or awardOpen-market sale
- Sep 19, 2023-$6,834NKTRSEC Form 4: Chess Robert sold $6,834 worth of shares (10,200 units at $0.67), decreasing direct ownership by 4% to 274,773 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Feb 7, 2023TWSTSEC Form 4: Chess Robert was granted 8,212 shares, increasing direct ownership by 15% to 62,464 unitsForm 4Grant or award
- Sep 22, 2022-$16.3KNKTRSEC Form 4: Chess Robert sold $16,269 worth of shares (5,100 units at $3.19) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 228,179 unitsForm 4Open-market sale10b5-1 plan
- Sep 16, 2022NKTRSEC Form 4: Chess Robert was granted 10,200 shares, increasing direct ownership by 5% to 233,279 unitsForm 4Grant or award
- Feb 8, 2022TWSTSEC Form 4: Chess Robert was granted 3,491 shares, increasing direct ownership by 7% to 54,252 unitsForm 4Grant or award
- Feb 4, 2022-$14.9KTWSTSEC Form 4: Chess Robert sold $14,896 worth of shares (253 units at $58.88), decreasing direct ownership by 0.50% to 50,761 units to satisfy withholding obligationForm 4Open-market sale
- Nov 1, 2021-$481KTWSTSEC Form 4: Chess Robert sold $480,614 worth of shares (4,000 units at $120.15) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 51,014 unitsForm 4Open-market sale10b5-1 plan
- Oct 21, 2021-$445KTWSTSEC Form 4: Chess Robert sold $444,540 worth of shares (3,700 units at $120.15) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 55,014 unitsForm 4Open-market sale10b5-1 plan
- Oct 19, 2021-$36KTWSTSEC Form 4: Chess Robert sold $36,000 worth of shares (300 units at $120.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.51% to 58,714 unitsForm 4Open-market sale10b5-1 plan
- Sep 22, 2021-$82.5KNKTRSEC Form 4: Chess Robert was granted 10,200 shares and sold $82,524 worth of shares (4,600 units at $17.94), increasing direct ownership by 2% to 279,873 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Sep 10, 2021-$481KTWSTSEC Form 4: Chess Robert sold $480,908 worth of Common Stock (4,000 units at $120.23), decreasing direct ownership by 6% to 59,014 unitsForm 4Open-market sale10b5-1 plan
- Sep 9, 2021-$293KNKTRSEC Form 4: Chess Robert exercised 18,279 units of Common Stock at a strike of $13.80 and sold $292,670 worth of Common Stock (18,279 units at $16.01)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 24, 2021NKTRSEC Form 4: Chess Robert gifted 6,300 units of Common Stock and received a gift of 6,300 units of Common Stock, decreasing direct ownership by 2% to 274,273 unitsForm 4Gift
- Jul 22, 2021-$96.1KNKTRSEC Form 4: CHESS ROBERT exercised 5,721 units of Common Stock at a strike of $13.80 and sold $96,148 worth of Common Stock (5,721 units at $16.81)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 12, 2021-$504KTWSTSEC Form 4: CHESS ROBERT sold $503,647 worth of Common Stock (4,000 units at $125.91), decreasing direct ownership by 6% to 63,014 unitsForm 4Open-market sale10b5-1 plan
- Jun 23, 2021-$480KTWSTSEC Form 4: CHESS ROBERT sold $480,409 worth of Common Stock (4,000 units at $120.10), decreasing direct ownership by 6% to 67,014 unitsForm 4Open-market sale10b5-1 plan
- May 12, 2021-$155KNKTRSEC Form 4: CHESS ROBERT exercised 8,000 units of Common Stock at a strike of $13.80 and sold $154,720 worth of Common Stock (8,000 units at $19.34)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 14, 2021-$152KNKTRSEC Form 4: CHESS ROBERT exercised 8,000 units of Common Stock at a strike of $13.80 and sold $151,840 worth of Common Stock (8,000 units at $18.98)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 4, 2020TWSTSEC Form 4 filed by Robert ChessForm 4Grant or award
- Jul 23, 2019TWSTSEC Form 4 filed by Robert ChessForm 4Grant or award
- Feb 5, 2021-$113KTWSTSEC Form 4: Robert Chess sold $112,635 worth of Common Stock (706 units at $159.54), decreasing ownership by 0.98% to 71,014 unitsForm 4Open-market sale10b5-1 plan
- Feb 3, 2021TWSTSEC Form 4: Robert Chess was granted 486 units of Common Stock, increasing ownership by 0.68% to 71,720 unitsForm 4Grant or award
Compare Robert Chess with
- Robert Chess vs Paula Green1 shared
- Robert Chess vs Adam Laponis1 shared
- Robert Chess vs Dennis Cho1 shared
- Robert Chess vs Emily M. Leproust1 shared
- Robert Chess vs Patrick John Finn1 shared
- Robert Chess vs Robert F. Werner1 shared
Other insiders at the same companies
- Adam LaponisTWST
- Paula GreenTWST
- Dennis ChoTWST
- Emily M. LeproustTWST
- Patrick John FinnTWST
- Robert F. WernerTWST
- Roy A WhitfieldNKTR
- R Scott GreerNKTR
- Diana BrainardNKTR
- Jeffrey Robert AjerNKTR
- Jonathan ZalevskyNKTR
- Howard W RobinNKTR
- Katryn BlakeTWST
- Melissa A. StarovasnikTWST
- Linda M RubinsteinNKTR
- Jan JohannessenTWST
Questions about Robert Chess
- What is Robert Chess's role at Nektar Therapeutics?
- Robert Chess reports to the SEC as director at Nektar Therapeutics (NKTR), according to the latest filing on September 26, 2026. Robert Chess has also filed as director at Twist Bioscience Corp (TWST).
- How many shares does Robert Chess own?
- After the latest filing that states it, Robert Chess directly owned 19,019 shares of Nektar Therapeutics (NKTR) and 21,084 shares of Twist Bioscience Corp (TWST). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Chess bought or sold stock recently?
- The most recent open-market sale was on August 7, 2026: sold 18,417 shares of Twist Bioscience Corp (TWST) for $2.04M at an average of $110.89.
- How do I get alerts when Robert Chess files?
- Follow Robert Chess on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Chess filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert Chess (SEC CIK 0001227886). Totals count each trade once, skipping amendments whose original is on file, from Feb 6, 2021 on. View on SEC EDGAR